Generate Biomedicines, Inc.
- GENB
- NASDAQ
- Biotechnology
- AI Drug Discovery
- Protein Therapeutics
$12.64
Today +4.52%Quote Oct 19, 2026, 06:39 PM UTC
−29.38%over the last month
Max drawdown −30.8%From 1-month high −30.8%3 months −11.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Generate Biomedicines
Generate Biomedicines, Inc. is a U.S.-based company pioneering generative biology, leveraging machine learning for the discovery and advancement of novel protein therapeutics. Their core approach involves developing drugs using protein-based modalities.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
312
Market value
$1.62B
Quote Oct 19
Floor
$12.31
2.6% below price
Resistance
$13.08
3.5% above price
Price vs analyst targets
2 analysts
Lowest target
$22.00Highest target
$30.00
$22.00Highest target
$30.00
- Price $12.64
- Average target $26.00
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 106% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about GENBPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free